Evaluation of SARS-CoV-2 Rapid Antigen Tests in Use on the Isle of Youth, Cuba.
Saylí González-FialloIdorka Mena-RodríguezPercy Castro-BatistaVíctor M Doeste-HernándezViviana Louit-LaboritPublished in: MEDICC review (2022)
The index values validate use of the SARS- CoV-2 rapid antigen test until prevalence falls below 2.5%, since as SARS-CoV-2 infection prevalence decreases, so does the predictive value of the PCR result. The use of the SARS-CoV-2 rapid antigen test on the Isle of Youth, Cuba, was decisive in the pandemic's clinical- epidemiological management.